6Byers PH. Determination of the molecular basis of Marfan syndrome :a growth industry. J Clin Invest, 2004, 114(2): 161-163
7Loeys BL, Matthys DM, De Paepe AM. Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management. Acta Clin Belg, 2003, 58(1 ): 3-11
8Vollbrandt T, Tiedemann K, EI-Hallous E, et al. Consequences of cystcine mutations in calcium-binding epidermal growth factor modules of fibrillin- 1. J Biol Chem, 2004,279(31 ): 32924-32931
9Corson GM, Charbonneau NL, Keene DR, et al.Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues, Genomics, 2004,83 (3):461-472
10Uyeda T, Takahashi T, Eto S, et al.Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marian syndrome patients. J Hum Genet, 2004, 49( 8 ): 404-407
